Trial Profile
Phase II trial of AR1008 for treatment of obesity
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 20 Oct 2016
Price :
$35
*
At a glance
- Drugs AR 1008 (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 20 Oct 2016 New trial record
- 01 Jun 2016 According to an AriBio media release, this trial will be conducted in 2017.